Growth Metrics

Rigel Pharmaceuticals (RIGL) Cash & Equivalents (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -39.84%
Dec 31, 2025 -16.39%
Sep 30, 2025 -9.12%
Jun 30, 2025 16.79%
Mar 31, 2025 -19.42%
Dec 31, 2024 9.78%
Sep 30, 2024 43.38%
Jun 30, 2024 40.98%
Mar 31, 2024 -22.00%
Dec 31, 2023 -27.81%
Sep 30, 2023 -6.96%
Jun 30, 2023 21.17%
Mar 31, 2023 64.70%
Dec 31, 2022 -18.10%
Sep 30, 2022 9.80%
Jun 30, 2022 10.22%
Mar 31, 2022 30.65%
Dec 31, 2021 -37.87%
Sep 30, 2021 -64.16%
Jun 30, 2021 323.12%
Mar 31, 2021 -34.00%
Dec 31, 2020 -16.94%
Sep 30, 2020 0.27%
Jun 30, 2020 -19.36%
Mar 31, 2020 100.81%
Dec 31, 2019 -42.39%
Sep 30, 2019 -11.61%
Jun 30, 2019 -40.79%
Mar 31, 2019 -2.13%
Dec 31, 2018 24.13%
Sep 30, 2018 -5.52%
Jun 30, 2018 62.19%
Mar 31, 2018 4.79%
Dec 31, 2017 47.96%
Sep 30, 2017 -20.59%
Jun 30, 2017 -18.81%
Mar 31, 2017 127.68%
Dec 31, 2016 -32.05%
Sep 30, 2016 4.02%
Jun 30, 2016 74.83%
Mar 31, 2016 -67.16%
Dec 31, 2015 12.65%
Sep 30, 2015 123.12%
Jun 30, 2015 -59.53%
Mar 31, 2015 180.98%
Dec 31, 2014 18.64%
Sep 30, 2014 -46.34%
Jun 30, 2014 60.17%
Mar 31, 2014 -28.50%
Dec 31, 2013 30.09%
Sep 30, 2013 -26.69%
Jun 30, 2013 -35.98%
Mar 31, 2013 2.02%
Dec 31, 2012 24.94%
Sep 30, 2012 2.49%
Jun 30, 2012 18.69%
Mar 31, 2012 18.25%
Dec 31, 2011 -0.26%
Sep 30, 2011 -56.50%
Jun 30, 2011 67.09%
Mar 31, 2011 189.58%
Dec 31, 2010 -59.76%
Sep 30, 2010 -31.56%